BRIEF-Canbridge Pharmaceuticals Says Velaglucerase-Beta Injection Approved In China

Reuters
20 May
BRIEF-Canbridge Pharmaceuticals Says Velaglucerase-Beta Injection Approved In China

May 20 (Reuters) - Canbridge Pharmaceuticals Inc 1228.HK:

  • VELAGLUCERASE-BETA FOR INJECTION APPROVED IN CHINA FOR GAUCHER DISEASE

  • INJECTION APPROVED BY NMPA

Further company coverage: 1228.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10